Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by University Hospital, Brest
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
University Hospital, Brest Identifier:
First received: May 3, 2013
Last updated: November 29, 2016
Last verified: November 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2022
  Estimated Primary Completion Date: June 2021 (Final data collection date for primary outcome measure)